ODB lists Afinitor (everolimus) for NETs of Gastrointestinal or Lung origin

By | November 24th, 2017|News|

We are pleased to announce that Ontario Drug Benefit (ODB) has listed Afinitor (everolimus) for the treatment of patients with GI/Lung NET, effective November 20, 2017 through the Exceptional Access [...]

World NET Cancer Day a Success in Canada

By | November 14th, 2017|Awareness|

On Friday, November 10th, 2017 – World NET Cancer Day, businesses and coffee shops around the world raised awareness about NETs using special coffee cups designed for the day. CNETS [...]

Diagnostic Scan – Ga68

By | October 4th, 2017|Treatment News|

The Gallium 68 scan, used with functional PET imaging, is a nuclear medicine scan that relies on the over-expression of somatostatin receptors to visualize tumours. NETs typically express several somatostatin receptor subtypes in [...]

Somatuline (lanreotide) Access in Manitoba & Alberta

By | October 2nd, 2017|Treatment News|

As we advised previously, in July of this year the Manitoba government issued a bulletin http://www.gov.mb.ca/health/mdbif/…/bulletins/bulletin93.pdf that indicated a change in the listing for Somatuline (from 1 to 3 and no access [...]

Caprelsa (vandetanib) for Medullary Thyroid NETs

By | October 2nd, 2017|Treatment News|

Caprelsa is indicated for the treatment of symptomatic or progressive medullary thyroid cancer (MTC) in adult patients with unresectable locally advanced or metastatic disease.   An application for this drug was [...]

Afinitor (everolimus) for NETs of Gastrointestinal or Lung origin

By | October 2nd, 2017|Treatment News|

Afinitor is currently paid for by provincial drug plans for patients with well-or moderately differentiated neuroendocrine tumours of pancreatic origin (pNET), in patients with unresectable, locally advanced or metastatic disease. [...]

Dr. Suzanne Richter

By | April 4th, 2017|News|

It is with profound sadness that we share the news of the passing of Dr. Suzanne Richter, Medical Oncologist on the NET team at London Health Sciences Centre.  This is [...]

CCO to provide Ga68 Scan to Ontario patients

By | March 28th, 2017|Clinical Trial, Education, Treatment News|

CCO to provide Ga-Octreotate to Ontario patients free of charge in Sherbrooke A message from Helena Senta: “At this time, CCO is proceeding with PET scan approval for the [...]

Thank you

By | February 15th, 2017|News|

Thank you to all our donors and volunteers! As we start anew into 2017, CNETS Canada would like to acknowledge and thank all our donors and volunteers for their generosity. [...]

Campaign Shines Spotlight on Rare Cancer

By | November 9th, 2016|Awareness, News|

Media Release Campaign Shines Spotlight on Rare Cancer on November 10th –World NET Cancer Day Toronto, ON – November 10th, 2016 – Today is World NET Cancer Day. To raise [...]